Estrogen Receptor Positive Breast Cancer Completed Phase 2 Trials for Entinostat (DB11841)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00676663Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast CancerTreatment